[Form 4] Honeywell International, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lucian Boldea, President and CEO, IA of Honeywell International Inc. (HON), reported multiple stock option exercises and open-market sales on 08/27/2025. He exercised 17,594 options at $171.73, 11,903 options at $199.60, and 6,684 options at $197.68 to acquire the same number of common shares. On the same date he sold matching amounts: 17,594 shares at a weighted-average price of $221.6036, 11,903 shares at $221.6036, 6,684 shares at $221.6036, and an additional 5,968 shares at $221.4404. Following these transactions, the reporting person beneficially owned 16,302 shares directly, with an additional 259.1954 indicated as held indirectly in a 401(k) plan.

The Form 4 lists the exercised options' original grant details and vesting schedules and discloses that the reported sale prices were executed in multiple transactions (range noted in footnote). These are routine officer option exercises and subsequent share sales reported under Section 16.

Positive

• Full disclosure of option grants and vesting schedules for the exercised option lots, enabling investor assessment of timing and dilution
• Sales reported with weighted-average prices and a footnote offering per-trade breakdowns, supporting transparency
• Transactions appear to be routine exercises and sales, consistent with standard executive compensation monetization

Negative

• Direct beneficial ownership reduced to 16,302 shares following the reported transactions
• Additional open-market sales (5,968 shares at $221.4404) further decrease insider holdings compared with pre-transaction totals

Insights

Financial Analyst

TL;DR: Officer exercised vested options and sold shares the same day, modestly reducing direct holdings to 16,302 shares.

The transactions reflect simultaneous option exercises and open-market sales on 08/27/2025. Exercised option lots totaled 36,181 shares acquired across three strike prices ($171.73, $199.60, $197.68). Reported sales matched those acquired amounts plus an additional 5,968-share sale, executed at weighted-average prices around $221.60. These actions are typical for monetizing option gains and do not, by themselves, indicate a change in company fundamentals. From an investor-impact perspective, the moves slightly increase float but are unlikely to be material relative to Honeywell’s market capitalization.

Corporate Governance Expert

TL;DR: Insider compliance appears complete; Form 4 discloses option grants, vesting schedules, and sales with weighted-average prices.

The filing includes grant and vesting details for options from the 2016 Stock Incentive Plan, with clear footnotes explaining vesting tranches. Sales were reported with a weighted-average price and a footnote offering to provide per-trade price breakdowns on request, which supports regulatory transparency. The reporting person remains a named officer and filed the disclosure timely. No regulatory exceptions, plan designation, or 10b5-1 indicator is explicitly marked on the face of the form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOLDEA LUCIAN

(Last) (First) (Middle)

855 S. MINT STREET

(Street)

CHARLOTTE NC 28202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HONEYWELL INTERNATIONAL INC [ - ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO, IA

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		M		17,594	A	$171.73	33,896	D
Common Stock	08/27/2025		S		17,594	D	$221.6036(1)	16,302	D
Common Stock	08/27/2025		M		11,903	A	$199.6	28,205	D
Common Stock	08/27/2025		S		11,903	D	$221.6036(1)	16,302	D
Common Stock	08/27/2025		M		6,684	A	$197.68	22,986	D
Common Stock	08/27/2025		S		6,684	D	$221.6036(1)	16,302	D
Common Stock	08/27/2025		S		5,968	D	$221.4404	10,334	D
Common Stock								259.1954	I	Held in 401(k) plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options	$171.73	08/27/2025		M			17,594	(2)	10/02/2032	Common Stock	17,594	$0	17,593	D
Employee Stock Options	$199.6	08/27/2025		M			11,903	(3)	02/09/2033	Common Stock	11,903	$0	11,902	D
Employee Stock Options	$197.68	08/27/2025		M			6,684	(4)	02/15/2034	Common Stock	6,684	$0	20,050	D

Explanation of Responses:

1. The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.2250 to $$221.9300, inclusive. The Reporting Person undertakes to provide to Honeywell International Inc, any security holder of Honeywell International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The Employee Stock Options were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates with 17,594 options fully vested and 8,796 options vesting on October 3, 2025 and 8,797 options vesting on October 3, 2026.

3. The Employee Stock Options were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates with 11,903 options fully vested and 5,951 options vesting on each of February 10, 2026 and February 10, 2027.

4. The Employee Stock Options were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates with 6,684 options fully vested and 6,683 options vesting on each of February 16, 2026 and February 16, 2027 and 6,684 options vesting on February 16, 2028.

Remarks:

	Richard Kent for Lucian Boldea	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HON insider Lucian Boldea do on 08/27/2025?

He exercised 17,594, 11,903, and 6,684 employee stock options and sold those shares the same day, plus an additional 5,968 shares.

At what prices were the HON shares sold?

Sales were reported at weighted-average prices of approximately $221.6036 for several lots and $221.4404 for a 5,968-share sale; footnote indicates prices ranged from $221.2250 to $221.9300 for the larger sale.

How many HON shares does Lucian Boldea own after these transactions?

The Form 4 reports 16,302 shares beneficially owned directly after the transactions, plus 259.1954 indicated as held indirectly in a 401(k) plan.

Were the option grants and vesting details disclosed?

Yes. The filing discloses the grants under the 2016 Stock Incentive Plan and provides vesting schedules for each option tranche.

Does the Form 4 indicate these trades were part of a 10b5-1 plan?

The form does not explicitly mark any box or footnote indicating the transactions were made pursuant to a 10b5-1 trading plan.

Who signed the Form 4 and when?

The form is signed by Richard Kent for Lucian Boldea and dated 08/28/2025.